Portal de Periódicos da CAPES

Management of Recurrent Priapism With Epinephrine Self-Injection and Gonadotropin-Releasing Hormone Analogue

1995; Lippincott Williams & Wilkins; Volume: 153; Issue: 1 Linguagem: Inglês

10.1097/00005392-199501000-00054

1527-3792

Jeffrey Steinberg, Robert C. Eyre,

Sexuality, Behavior, and Technology

No AccessJournal of UrologyClinical Urology: Case Report1 Jan 1995Management of Recurrent Priapism With Epinephrine Self-Injection and Gonadotropin-Releasing Hormone Analogue Jeffrey Steinberg and Robert C. Eyre Jeffrey SteinbergJeffrey Steinberg and Robert C. EyreRobert C. Eyre View All Author Informationhttps://doi.org/10.1097/00005392-199501000-00054AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail A case of recurrent priapism in a young black man without sickle cell anemia is reported. Due to almost daily episodes of prolonged painful erections, the patient was instructed in intracorporeal injection using an epinephrine self-injection kit, which provided complete detumescence on 31 occasions. The patient refused surgical intervention and was treated with monthly intramuscular gonadotropin-releasing hormone analogue. Priapism episodes completely abated by the second and final monthly gonadotropin-releasing hormone analogue injection without recurrence during 4 months of followup. Normal erectile function was maintained during and after gonadotropin-releasing hormone analogue therapy. Epinephrine self-injection and gonadotropin-releasing hormone analogue may be effective treatment modalities in select cases of recurrent priapism. References 1 : Drug-induced priapism. Its aetiology, incidence and treatment. Med. Toxicol. Adverse Drug Exp.1989; 4: 46. Google Scholar 2 : Trazodone and priapism. Amer. J. Psychiat.1983; 140: 1362. Google Scholar 3 : Priapism induced by chlorpromazine and trazodone: mechanism of action. J. Urol.1987; 137: 1039. Link, Google Scholar 4 : Intracorporeal self-injection with epinephrine as treatment for idiopathic recurrent priapism. Eur. Urol.1990; 17: 95. Google Scholar 5 : Erection and priapism: a new physiopathological concept. Urol. Int.1983; 38: 138. Google Scholar 6 : Priapism: a refined approach to diagnosis and treatment. J. Urol.1986; 136: 104. Link, Google Scholar 7 : Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet1985; 2: 1274. Google Scholar 8 : Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J. Urol.1993; 150: 475. Link, Google Scholar From the Division of Urology, Deaconess Hospital and Harvard Medical School, Boston, Massachusetts© 1995 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byMONTAGUE D, JAROW J, BRODERICK G, DMOCHOWSKI R, HEATON J, LUE T, NEHRA A and SHARLIP I (2018) American Urological Association Guideline On The Management of PriapismJournal of Urology, VOL. 170, NO. 4 Part 1, (1318-1324), Online publication date: 1-Oct-2003. Volume 153Issue 1January 1995Page: 152-153 Advertisement Copyright & Permissions© 1995 by American Urological Association, Inc.MetricsAuthor Information Jeffrey Steinberg More articles by this author Robert C. Eyre More articles by this author Expand All Advertisement PDF downloadLoading ...